Search results
Showing 151 to 200 of 453 results for antibiotics or antimicrobial
NICE public committee meetings supports our commitment to having processes in place that are rigorous, open, and transparent.
Discontinued Reference number: GID-NG10163
NG195/10 Question Intrapartum antibiotics: What is the clinical and cost effectiveness of intrapartum antibiotics for women...
prolapse Infections Cystitis (urinary tract infection, UTI): taking an antibiotic Mental health and nervous system conditions Should I...
NICE has developed a medtech innovation briefing (MIB) on LQD Spray for treating acute and chronic wounds .
Acute upper gastrointestinal bleeding in over 16s: management (CG141)
This guideline covers how upper gastrointestinal bleeding can be effectively managed in adults and young people aged 16 years and older. It aims to identify which diagnostic and therapeutic steps are useful so hospitals can develop a structure in which clinical teams can deliver an optimum service for people who develop this condition.
View recommendations for CG141Show all sections
AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis (MIB46)
NICE has developed a medtech innovation briefing (MIB) on the AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis
Read biographies for all members of NICE's indicator advisory committee.
Read biographies for all members of NICE's indicator advisory committee.
This guideline covers the routine antenatal care that women and their babies should receive. It aims to ensure that pregnant women are offered regular check-ups, information and support.
Evidence-based recommendations on colistimethate sodium (Colobreathe) and tobramycin (TOBI Podhaler) dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis in people of 6 years and over.
What is the most clinically and cost-effective treatment for diverticular disease?
recommendationsVery limited evidence was identified on a high fibre diet, antibiotics, aminosalicylates, probiotics, symbiotics and...
View a complete list of indicators currently being developed. Our indicators measure outcomes that reflect the quality of care or processes.
Details of the chair and core members of public health advisory committee E.
This evidence summary has been updated and replaced by NICE antimicrobial health technology evaluation guidance on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.
Find out more about NICE technology appraisals advisory committee D members
Find out more about NICE technology appraisals advisory committee D members
Alcohol-use disorders: diagnosis and management of physical complications (CG100)
This guideline covers care for adults and young people (aged 10 years and older) with physical health problems that are completely or partly caused by an alcohol-use disorder. It aims to improve the health of people with alcohol-use disorders by providing recommendations on managing acute alcohol withdrawal and treating alcohol-related conditions.
Details of the chair and core members of the public health advisory committee.
This evidence summary has been updated and replaced by NICE antimicrobial health technology evaluation guidance on ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections.
Neonatal infection: antibiotics for prevention and treatment - update
In development Reference number: GID-NG10456 Expected publication date: 13 May 2026
The standing committees were responsible for the development of our public health guidance.
Question Antibiotics for suspected early-onset infection: What is the incidence and severity of adverse effects with...
NG119/4 Question Prophylactic antibiotics for respiratory disorders:- Are prophylactic antibiotics clinically and cost...
This guideline covers the care of women with a singleton pregnancy at increased risk of, or with symptoms and signs of, preterm labour (before 37 weeks), and women with a singleton pregnancy having a planned preterm birth. It aims to reduce the risks of preterm birth for the baby and describes treatments to prevent or delay early labour and birth.
Details about the chair and core members of NICE public health advisory committee F.
Membership details, terms of reference, future meeting dates and past meeting minutes for our indicator advisory committee.
Membership details, terms of reference, future meeting dates and past meeting minutes for our indicator advisory committee.
Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.
Membership details, terms of reference and future meeting dates for our quality standards advisory committee.
Question Antibiotics for suspected early-onset infection: What is the incidence in England and Wales of resistance to commonly used...
This guide gives an overview of the process for developing evidence summaries. Evidence summaries provide advice but do not include recommendations and are not formal NICE guidance
Recommendation ID NG195/4 Question Antibiotics for suspected early-onset neonatal infection: What is the optimal duration of treatment
Recommendation ID NG195/14 Question Antibiotics for suspected early-onset infection: What are the core exposures and outcomes that should
SecurePort IV tissue adhesive for use with percutaneous catheters (MIB288)
NICE has developed a medtech innovation briefing (MIB) on SecurePort IV tissue adhesive for use with percutaneous catheters .
Membership details, terms of reference and future meeting dates for our quality standards advisory committee.
This guideline covers care and support for adults with cerebral palsy. It aims to improve health and wellbeing, promote access to services and support participation and independent living.
Evidence-based recommendations on collagen injection for vocal cord augmentation. This involves injecting collagen into the affected vocal cord(s).
View recommendations for HTG79Show all sections
Sections for HTG79
Prophylactic antibiotics for preventing exacerbations: - What is the long-term clinical and cost effectiveness of prophylactic...
Question Prophylactic antibiotics for preventing exacerbations:- What is the comparative effectiveness of different...
Prophylactic antibiotics for preventing exacerbations:- What is the comparative effectiveness of seasonal versus continuous prophylactic...
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115)
This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer.
dysfunction, which management strategies (including the use of prophylactic antibiotics and various invasive and non-invasive techniques...
This guideline covers the care of pregnant women and pregnant trans and non-binary people and their babies during labour and immediately after birth. It focuses on women and pregnant people who give birth between 37 and 42 weeks of pregnancy (‘term’). The guideline helps women and pregnant people to make informed choices about where to have their baby and about their care in labour. It also aims to reduce variation in aspects of care.
View recommendations for NG235Show all sections
Sections for NG235
- Overview
- Recommendations
- Recommendations for research
- Rationale and impact
- Context
- Appendix A: Adverse outcomes for different places of birth
- Appendix B: Outcomes for different places of birth – by BMI at booking
- Appendix C: Outcomes for intravenous remifentanil patient-controlled analgesia (PCA) compared with intramuscular pethidine
practical guidance that is usable in real life.Avril Tucker, primary care antimicrobial pharmacist and NICE committee member Stay...
More detail about Interventional Procedures Advisory Committee (IPAC) registration, meeting arrangements and types of attendee.
More detail about Interventional Procedures Advisory Committee (IPAC) registration, meeting arrangements and types of attendee.
NICE has developed a medtech innovation briefing (MIB) on The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs .
and recovery and efficient use of resources. NICE committee meetings Antimicrobial evaluation committee Diagnostics advisory committee...
and recovery and efficient use of resources. NICE committee meetings Antimicrobial evaluation committee Diagnostics advisory committee...